FOSSENCE® is a clinically studied molecule. It has been studied for postprandial glycemic and insulinimic response, (alone or when mixed with available carbohydrates in solid or liquid form) and does not increase post-prandial glucose and insulin level.
Our another study evaluated the effect of FOS in healthy humans at different dosage levels on beneficial fermentative
microbes (Bifdobacterium, Lactobacillus) and concluded that FOS consumption increased the relative abundance of operational taxonomix units (OTUs) belonging to Bifidobacterium and Lactobacillus and increased overall bacterial diversity and butyrate producing microbes.
It is our constant endeavor to add value in our offerings to customers and we may look into more clinical trials to support any claim that is aligned with our FOSSENCE® business goals.
